[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364379-105":59,"doc-detail-364379-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","potential-prognostic-and-immunologic-significances-of-adam8-in-clear-cell-renal-cell-carcinoma","Potential prognostic and immunologic significances of ADAM8 in clear cell renal cell carcinoma","","A Disintegrin And Metalloproteinase 8 (ADAM8) is implicated in cancer development, yet its clinical value in clear cell renal cell carcinoma (ccRCC) remains unclear. Using bioinformatics analyses based on The Cancer Genome Atlas, with validation from Gene Expression Omnibus and immunohistochemistry, the study assesses ADAM8 expression, prognostic effects, enriched signaling pathways, and links to tumor microenvironment immune infiltration via CIBERSORT. It also evaluates immunotherapy response using The Cancer Immunome Atlas and proposes candidate drugs via Connectivity Map. Results indicate higher ADAM8 predicts worse outcomes and stronger immune and immunotherapy associations, with multiple potential therapeutic groups.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/potential-prognostic-and-immunologic-significances-of-adam8-in-clear-cell-renal-cell-carcinoma/364379/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/potential-prognostic-and-immunologic-significances-of-adam8-in-clear-cell-renal-cell-carcinoma/364379.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of investigating ADAM8 in clear cell renal cell carcinoma (ccRCC)?","Question",{"text":113,"@type":114},"To determine the prognostic and immunologic significance of ADAM8 in ccRCC from a bioinformatics perspective.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was ADAM8 expression and prognosis evaluated?",{"text":118,"@type":114},"Expression and prognosis were analyzed in ccRCC using The Cancer Genome Atlas, validated with Gene Expression Omnibus, and confirmed with immunohistochemistry.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationships did the study find between ADAM8 and the tumor microenvironment or immunotherapy?",{"text":122,"@type":114},"ADAM8 expression correlated strongly with immune cell infiltration and with immunotherapy response, and higher ADAM8 levels were associated with poorer prognosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},364379,1790243984,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","®  \n Clinical Trial/Experimental Study   \nPotential prognostic and immunologic significances ofADAM8 in clear cell renal cell carcinoma  \nMing Chuan Chu, MMa , Zhi Lei Zhang, MDa , Zhi Qiang Wang, MMb , Zong Yang Li, MMa , Yong Shun Guo, MDa ,*  \n\n| Abstract\u003Cbr>Background: A Disintegrin And Metalloproteinase 8 (ADAM8) has been implicated in the development and progression of several cancers. However, further studies are needed to determine the value of ADAM8 in ccRCC. The research aimed to investigate the prognostic and immunologic significance of ADAM8 in ccRCC from the perspective of bioinformatics.\u003Cbr>Methods: We analyzed the expression and prognosis ofADAM8 in ccRCC using The Cancer Genome Atlas and validated it with Gene Expression Omnibus and immunohistochemistry assay. Functional enrichment analysis was conducted to investigate the signaling pathways. And the relationship between ADAM8 and the tumor microenvironment was analyzed using the CIBERSORT algorithm. Furthermore, the study explored the response to immunotherapy of ccRCC by using The Cancer Immunome Atlas database data. Potential drugs for treating ccRCC were discovered using the Connectivity Map.\u003Cbr>Results: The expression of ADAM8 was significantly elevated in ccRCC tissues. CcRCC patients with higher levels of ADAM8 expression had poorer prognosis, and ADAM8 was shown to be an independent predictive risk factor for ccRCC. The functional enrichment analysis revealed relevant signaling pathways. Furthermore, we found that ADAM8 expression correlates strongly with the extent of immune cell infiltration and immunotherapy. Finally, 4 groups of potential drugs for the treatment of ccRCC were identified.\u003Cbr>Conclusion: Our research found that ADAM8 could have a significant impact on the development, progression, immunotherapy and prognosis of patients with ccRCC, and may be a promising prognostic and immunotherapeutic target. The study provides anew insights that may be useful in helping to manage ccRCC.\u003Cbr>Abbreviations: ADAM8 = A Disintegrin And Metalloproteinase 8, BP = biological processes, CC = cellular components, ccRCC = clear cell renal cell carcinoma, CMap = Connectivity Map, CTLA-4 = cytotoxic T lymphocyte antigen-4, DEG = differentially expressed gene, ECM = extracellular matrix, GEO = Gene Expression Omnibus, GO = Gene Ontology, GSEA = Gene Set Enrichment Analysis, IDO 1 = indoleamine 2,3-dioxygenase, IHC = Immunohistochemistry, IPS = immunophenoscores, KYN = kynurenine, MF = molecular functions, MUC1 = mucin-1, NCS = normalized connectivity scores, NDUFA4L2 = NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 4-like 2, PD-1 = programmed death-1, TCGA = The Cancer Genome Atlas, TCIA = The Cancer Immunome Atlas, TME = Tumor microenvironment. |\n| --- |\n| Keywords: ADAM8 , bioinformatics, clear cell renal cell carcinoma, immutherapy, prognosis |\n\n1. Introduction  \nKidney cancer is a prevalent tumor of the genitourinary system, resulting in approximately 400,000 diagnoses and 170,000 fatalities worldwide per annum. [1] Renal cell carcinoma (RCC) is a type of kidney cancer, of which ccRCC is the most common histological subtype, accounting for approximately 70% of cases. [2] Early-stage patients with ccRCC generally undergo surgical resection with positive outcomes, whereas advanced  \npatients with recurrence and metastases usually receive targeted therapies and immunotherapies, often with poor prognosis. [3,4] Although some molecular markers have been investigated, the prognosis for patients with ccRCC has not improved markedly.[5]  \nADAM8, a disintegrin and metalloprotease domain 8, is a type I transmembrane protein.[6,7] According to reports, ADAM8 is involved with several inflammatory diseases and  \nThe authors have no funding and conflicts of interest to disclose.  \nAll data generated or analyzed during this study are included in this published article [and its supplementary information files].  \na Department of Urology, Weifang People’s Hospital, Shando","cbCaiuLzxxwNJZ5G","https://ap.wps.com/l/cbCaiuLzxxwNJZ5G","pdf",5901601,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the purpose of investigating ADAM8 in clear cell renal cell carcinoma (ccRCC)?\",\"answer\":\"To determine the prognostic and immunologic significance of ADAM8 in ccRCC from a bioinformatics perspective.\"},{\"question\":\"How was ADAM8 expression and prognosis evaluated?\",\"answer\":\"Expression and prognosis were analyzed in ccRCC using The Cancer Genome Atlas, validated with Gene Expression Omnibus, and confirmed with immunohistochemistry.\"},{\"question\":\"What relationships did the study find between ADAM8 and the tumor microenvironment or immunotherapy?\",\"answer\":\"ADAM8 expression correlated strongly with immune cell infiltration and with immunotherapy response, and higher ADAM8 levels were associated with poorer prognosis.\"}]","Potential prognostic and immunologic significances of ADAM8 in clear cell renal cell carcinoma | PDF",1790157345,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a0474964778a3fcea06f9d3fe9f3d05.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9acbd42b6e0742ef17230c343701c594.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68b345cf02ba7372f187da24bc72ffaa.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/358ccd2ef4c96c26a8bf6d98a335e533.webp",980,1306]